{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:13:14Z","timestamp":1791097994451,"version":"4.1.0"},"reference-count":41,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1507\/endocrj.k06-058","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T05:47:25Z","timestamp":1162273645000},"page":"615-620","source":"Crossref","is-referenced-by-count":3,"title":["No Evidence of ARAF, CRAF and MET Mutations in BRAFT1799A Negative Human Papillary Thyroid Carcinoma"],"prefix":"10.1507","volume":"53","author":[{"given":"Atsushi","family":"KUMAGAI","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"},{"name":"Takashi Nagai Memorial International Hibakusha Medical Center, Nagasaki University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"NAMBA","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"},{"name":"Takashi Nagai Memorial International Hibakusha Medical Center, Nagasaki University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"TAKAKURA","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"INAMASU","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"SAENKO","sequence":"additional","affiliation":[{"name":"International Health and Radiation Research, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"OHTSURU","sequence":"additional","affiliation":[{"name":"Takashi Nagai Memorial International Hibakusha Medical Center, Nagasaki University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"YAMASHITA","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"},{"name":"International Health and Radiation Research, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University"},{"name":"Takashi Nagai Memorial International Hibakusha Medical Center, Nagasaki University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63: 1454-1457."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030305"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M (2003) BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22: 4578-4580.","DOI":"10.1038\/sj.onc.1206706"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95: 625-627.","DOI":"10.1093\/jnci\/95.8.625"},{"key":"5","unstructured":"5. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA (2003) High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 63: 4561-4567."},{"issue":"16","key":"6","first-page":"4459","volume":"48","year":"1988","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Namba H, Gutman RA, Matsuo K, Alvarez A, Fagin JA (1990) H-ras protooncogene mutations in human thyroid neoplasms. J Clin Endocrinol Metab 71: 223-229.","DOI":"10.1210\/jcem-71-1-223"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1385\/EP:13:1:03"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, Biddinger PW, Nikiforov YE (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30: 216-222.","DOI":"10.1097\/01.pas.0000176432.73455.1b"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y, Yamashita S (2004) Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4280-4284.","DOI":"10.1210\/jc.2004-0172"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lima J, Trovisco V, Soares P, Maximo V, Magalhaes J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simoes M (2004) BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4267-4271.","DOI":"10.1210\/jc.2003-032224"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nikiforova MN, Ciampi R, Salvatore G, Santoro M, Gandhi M, Knauf JA, Thomas GA, Jeremiah S, Bogdanova TI, Tronko MD, Fagin JA, Nikiforov YE (2004) Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 209: 1-6.","DOI":"10.1016\/j.canlet.2003.12.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, Gauger P, Doherty G, Thompson NW, Hanash S, Koenig RJ, Nikiforov YE (2005) Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24: 6646-6656.","DOI":"10.1038\/sj.onc.1208822"},{"issue":"12","key":"14","first-page":"2549","volume":"7","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"key":"15","unstructured":"15. Ishigaki K, Namba H, Nakashima M, Nakayama T, Mitsutake N, Hayashi T, Maeda S, Ichinose M, Kanematsu T, Yamashita S (2002) Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 87: 3433-3440."},{"key":"16","unstructured":"16. Boon EM, van der Neut R, van de Wetering M, Clevers H, Pals ST (2002) Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 62: 5126-5128."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nakashima M, Meirmanov S, Naruke Y, Kondo H, Saenko V, Rogounovitch T, Shimizu-Yoshida Y, Takamura N, Namba H, Ito M, Abrosimov A, Lushnikov E, Roumiantsev P, Tsyb A, Yamashita S, Sekine I (2004) Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression. J Pathol 202: 446-455.","DOI":"10.1002\/path.1534"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63: 908-911.","DOI":"10.1002\/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashida N, Namba H, Kumagai A, Hayashi T, Ohtsuru A, Ito M, Saenko VA, Maeda S, Kanematsu T, Yamashita S (2004) A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells. Thyroid 14: 910-915.","DOI":"10.1089\/thy.2004.14.910"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, Tezuka H, Nakao H, Kawakami A, Migita K, Yamashita S, Matsunaga M, Ishikawa N, Ito K, Nagataki S (1989) Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab 68: 1174-1183.","DOI":"10.1210\/jcem-68-6-1174"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Huleihel M, Goldsborough M, Cleveland J, Gunnell M, Bonner T, Rapp UR (1986) Characterization of murine A-raf, a new oncogene related to the v-raf oncogene. Mol Cell Biol 6: 2655-2662.","DOI":"10.1128\/MCB.6.7.2655"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M (1998) Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 12: 1903-1929.","DOI":"10.1038\/sj.leu.2401215"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1999.4689"},{"issue":"3","key":"24","first-page":"345","volume":"5","year":"1990","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Winer MA, Wadewitz AG, Wolgemuth DJ (1993) Members of the raf gene family exhibit segment-specific patterns of expression in mouse epididymis. Mol Reprod Dev 35: 16-23.","DOI":"10.1002\/mrd.1080350104"},{"key":"26","unstructured":"26. Luckett JC, Huser MB, Giagtzoglou N, Brown JE, Pritchard CA (2000) Expression of the A-raf proto-oncogene in the normal adult and embryonic mouse. Cell Growth Differ 11: 163-171."},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(94)90133-3"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(02)00139-0"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.7.4378"},{"issue":"10","key":"30","first-page":"2213","volume":"12","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.38.24939"},{"issue":"47","key":"32","doi-asserted-by":"crossref","first-page":"30014","DOI":"10.1016\/S0021-9258(18)43982-8","volume":"269","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"issue":"11","key":"33","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/MCB.15.11.6430","volume":"15","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0270-7306","issn-type":"print"},{"issue":"10","key":"34","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1128\/MCB.14.10.6944","volume":"14","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0270-7306","issn-type":"print"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.13.7644"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.8.1940"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mitsutake N, Miyagishi M, Mitsutake S, Akeno N, Mesa Jr C, Knauf JA, Zhang L, Taira K, Fagin JA (2006) BRAF mediates RET\/PTC-induced MAPK activation in thyroid cells: functional support for requirement of the RET\/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis. Endocrinology 147: 1014-1019.","DOI":"10.1210\/en.2005-0280"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Fransen K, Klintenas M, Osterstrom A, Dimberg J, Monstein HJ, Soderkvist P (2004) Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25: 527-533.","DOI":"10.1093\/carcin\/bgh049"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Min WS, Kim SH, Lee JY, Yoo NJ, Lee SH (2005) Mutational analysis of the ARAF gene in human cancers. Apmis 113: 54-57.","DOI":"10.1111\/j.1600-0463.2005.apm1130108.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ruco LP, Stoppacciaro A, Ballarini F, Prat M, Scarpino S (2001) Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol 194: 4-8.","DOI":"10.1002\/path.847"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1038\/ng0597-68"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/5\/53_5_615\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T03:11:38Z","timestamp":1628046698000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/5\/53_5_615\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k06-058","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}